Regulation of Lens Fiber Cell Organization
Regulation of Lens Fiber Cell Organization
批准号:
8487408
负责人:
RENPING ZHOU
金额:
$34.3万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2015-06-30
关键词:
Adherens JunctionAgeAntibodiesBlindnessCadherinsCataractCell AdhesionCell CommunicationCell Differentiation processCell ShapeCellsCharacteristicsChimeric ProteinsConnexinsCytoplasmDefectDevelopmentDifferentiation AntigensDiseaseElectron MicroscopeEmbryoEnsureEph Family ReceptorsEphA2 ReceptorEphrin-A5EphrinsFamilyFiberFutureHealthHumanImmunohistochemistryIn Situ HybridizationKnockout MiceKnowledgeLeadLens FiberLens OpacitiesLigandsLight MicroscopeMediatingMolecularMorphologyN-CadherinNervous system structureOrganellesPathogenesisPhenotypePreventionRefractive IndicesRegulationRoleSignal TransductionStagingStructureTechniquesTestingTimeWestern Blottingaxon guidancefiber cellinsightlenslens transparencylight transmissionmutantnovelpostnatalreceptorreceptor-mediated signalingresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Lens transparency is made possible by a combination of the highly ordered organization of the lens fiber cells, their unique refractive index, and the lack of organelles in the fiber cells. The highly ordered arrangement of the lens fiber cells is critical for proper light transmission, and disruption of this structure by alterations of cell-cell interactions is likely to lead to cataracts. However, signals that regulate lens fiber cell interaction remain largely unknown. Our preliminary studies have identified a new class of molecules, the Eph tyrosine kinase receptor family that regulates lens cell organization. Inactivation of ephrin-A5, a ligand of the Eph receptors, leads to the disruption of N-cadherin localization, change in lens fiber cell shape, disorganization of lens cells, and the development of cataracts. We hypothesize that ephrin-A5, interacting with its receptor(s), regulates N-cadherin-mediated fiber cell adhesion to maintain proper lens cell organization. To test this hypothesis, we will: (1) Examine the spatial and temporal characteristics of the ephrin-A5-null lens, determine when and where during development the lens defects first occur, and whether the loss of ephrin-A5 results in disruptions of lens fiber cell differentiation. The morphology of the lens at different developmental stages will be analyzed using both light and electron microscope techniques. Antibodies against markers of lens cell differentiation will be used in immunohistochemical experiments to study the expression of differentiation markers. (2) Elucidate receptor mechanisms of ephrin-A5 in lens development by examining which specific Eph receptors are expressed in the developing lens and where they are expressed, using Real-Time PCR, in situ hybridization, and immunohistochemistry. Since the interaction between Eph receptors and ligands leads to bidirectional signaling, we plan to analyze whether receptor- mediated signaling, the ligand-mediated reverse signaling or both are required for lens development using selective inactivation of different receptor domains. (3) Study the molecular alterations that lead to cataracts in ephrin-A5-null mice. Preliminary studies have revealed a disruption of N-cadherin distribution in the lens fiber cells. We will determine whether ephrin-A5 receptors interact physically with adherens junction molecules, and analyze effects of the ligand on N-cadherin functions. To critically evaluate roles of N-cadherin in mediating ephrin-A5 function and lens cell adhesion, we plan also to examine expression of a N-cadherin-2-catenin fusion protein in a phenotypic rescue experiment. The proposed studies will establish roles of a previously unsuspected family of molecules in lens development and reveal novel regulations of N-cadherin functions. These studies will enhance our understanding of how lens cell interaction is regulated to ensure lens transparency and provide insights into the mechanisms of cataractogenesis.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
人类白内障 EPHA2 SAM 结构域突变改变受体稳定性和功能
DOI:
10.1371/journal.pone.0036564
发表时间:
2012
期刊:
PloS one
影响因子:
3.7
作者:
[Park JE, Son AI, Hua R, Wang L, Zhang X, Zhou R]
通讯作者:
Zhou R
DOI:
10.3390/genes4030334
发表时间:
2013-07-01
期刊:
Genes
影响因子:
3.5
作者:
[Park JE, Son AI, Zhou R]
通讯作者:
Zhou R
DOI:
10.1007/s11427-012-4318-7
发表时间:
2012-05
期刊:
SCIENCE CHINA-LIFE SCIENCES
影响因子:
9.1
作者:
[Son, Alexander, I, Park, Jeong Eun, Zhou RenPing]
通讯作者:
Zhou RenPing
Regulation of Lens Fiber Cell Organization
-
批准号:8281603
-
项目类别:
-
资助金额:$36.16万
-
财政年份:2009
-
负责人:RENPING ZHOU
-
依托单位:
Regulation of Lens Fiber Cell Organization
-
批准号:8091251
-
项目类别:
-
资助金额:$36.17万
-
财政年份:2009
-
负责人:RENPING ZHOU
-
依托单位:
Regulation of Lens Fiber Cell Organization
-
批准号:7728507
-
项目类别:
-
资助金额:$39.44万
-
财政年份:2009
-
负责人:RENPING ZHOU
-
依托单位:
Regulation of Lens Fiber Cell Organization
-
批准号:7876672
-
项目类别:
-
资助金额:$37.64万
-
财政年份:2009
-
负责人:RENPING ZHOU
-
依托单位:
EPH FAMILY RECEPTORS IN THE HIPPOCAMPOSEPTAL SYSTEM
-
批准号:6572333
-
项目类别:
-
资助金额:$8.64万
-
财政年份:2002
-
负责人:RENPING ZHOU
-
依托单位:
EPH FAMILY RECEPTORS IN THE HIPPOCAMPOSEPTAL SYSTEM
-
批准号:6301939
-
项目类别:
-
资助金额:$14.52万
-
财政年份:2000
-
负责人:RENPING ZHOU
-
依托单位:
EPH FAMILY RECEPTORS IN THE HIPPOCAMPOSEPTAL SYSTEM
-
批准号:6108486
-
项目类别:
-
资助金额:$14.52万
-
财政年份:1999
-
负责人:RENPING ZHOU
-
依托单位:
EPH MOLECULES IN OTOGENY OF BRAIN REWARD CIRCUITS
-
批准号:6342273
-
项目类别:
-
资助金额:$22.83万
-
财政年份:1998
-
负责人:RENPING ZHOU
-
依托单位:
EPH MOLECULES IN OTOGENY OF BRAIN REWARD CIRCUITS
-
批准号:2454566
-
项目类别:
-
资助金额:$18.99万
-
财政年份:1998
-
负责人:RENPING ZHOU
-
依托单位:
EPH MOLECULES IN OTOGENY OF BRAIN REWARD CIRCUITS
-
批准号:6137816
-
项目类别:
-
资助金额:$22.13万
-
财政年份:1998
-
负责人:RENPING ZHOU
-
依托单位:
EPH FAMILY RECEPTORS IN THE HIPPOCAMPOSEPTAL SYSTEM
-
批准号:6272135
-
项目类别:
-
资助金额:$14.14万
-
财政年份:1998
-
负责人:RENPING ZHOU
-
依托单位:
EPH MOLECULES IN OTOGENY OF BRAIN REWARD CIRCUITS
-
批准号:2856571
-
项目类别:
-
资助金额:$20.17万
-
财政年份:1998
-
负责人:RENPING ZHOU
-
依托单位:
EPH MOLECULES IN HIPPOCAMPAL TOPOGRAPHIC PROJECTIONS
-
批准号:2735719
-
项目类别:
-
资助金额:$19.73万
-
财政年份:1997
-
负责人:RENPING ZHOU
-
依托单位:
EPH MOLECULES IN HIPPOCAMPAL TOPOGRAPHIC PROJECTIONS
-
批准号:6149392
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1997
-
负责人:RENPING ZHOU
-
依托单位:
EPH MOLECULES IN HIPPOCAMPAL TOPOGRAPHIC PROJECTIONS
-
批准号:2388271
-
项目类别:
-
资助金额:$18.58万
-
财政年份:1997
-
负责人:RENPING ZHOU
-
依托单位:
EPH MOLECULES IN HIPPOCAMPAL TOPOGRAPHIC PROJECTIONS
-
批准号:2892323
-
项目类别:
-
资助金额:$21.71万
-
财政年份:1997
-
负责人:RENPING ZHOU
-
依托单位:
EPH FAMILY RECEPTORS & LIGANDS IN THE HIPPOCAMPAL SYSTEM
-
批准号:7392781
-
项目类别:
-
资助金额:$20.79万
-
财政年份:--
-
负责人:RENPING ZHOU
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: